These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2883201)

  • 61. The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements.
    Young MA; Meltzer HY
    Schizophr Bull; 1980; 6(1):88-101. PubMed ID: 6102797
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recall and recognition in mildly disturbed schizophrenics: the use of matched tasks.
    Calev A
    Psychol Med; 1984 May; 14(2):425-9. PubMed ID: 6146152
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Behavioral differences between acute and chronic schizophrenics: course of psychosis, effects of institutionalization, or sampling biases?
    Strauss ME
    Psychol Bull; 1973 May; 79(5):271-9. PubMed ID: 4145227
    [No Abstract]   [Full Text] [Related]  

  • 64. Benefits of correlating neuroleptic blood level and auditory distractibility.
    Terkelsen KG
    Am J Psychiatry; 1985 Dec; 142(12):1523-4. PubMed ID: 2866721
    [No Abstract]   [Full Text] [Related]  

  • 65. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE; Tune L
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Visuomotor performance of schizophrenic patients and normal controls in a picture viewing task.
    Gaebel W; Ulrich G; Frick K
    Biol Psychiatry; 1987 Oct; 22(10):1227-37. PubMed ID: 2889478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of phenothiazine withdrawal on proverb interpretation by chronic schizophrenics.
    Chapman LJ; Cameron R; Cocke JG; Pritchett T
    J Abnorm Psychol; 1975 Feb; 84(1):24-9. PubMed ID: 234133
    [No Abstract]   [Full Text] [Related]  

  • 68. Followup treatment and aftercare of discharged schizophrenic patients.
    Haase HJ
    Schizophr Bull; 1980; 6(4):619-26. PubMed ID: 6108609
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thinking patterns and patterning drugs.
    Seeman MV
    Can J Psychiatry; 1997 Apr; 42(3):247-8. PubMed ID: 9114939
    [No Abstract]   [Full Text] [Related]  

  • 70. Ten-year follow-up of schizophrenic patients on pipothiazine palmitate.
    Imlah NW; Murphy KP
    Curr Med Res Opin; 1985; 9(7):449-53. PubMed ID: 2863088
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Randomness and the "streaking" phenomenon: attentional anomalies in performance on the Whitaker Index of Schizophrenic Thinking (WIST).
    Fishkin SM; Lovallo WR; Whitaker LC; Pishkin V
    J Clin Psychol; 1979 Apr; 35(2):289-95. PubMed ID: 457887
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study.
    Usher K
    Aust N Z J Ment Health Nurs; 2001 Sep; 10(3):145-55. PubMed ID: 11493286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The AMDP-system in chronic hospitalized schizophrenics.
    Ban TA; Guy W; Wilson WH
    Compr Psychiatry; 1985; 26(4):370-4. PubMed ID: 2861972
    [No Abstract]   [Full Text] [Related]  

  • 74. The Whitaker Index of Schizophrenic Thinking (WIST) and thirteen systems for diagnosing schizophrenia.
    Leslie BA; Landmark J; Whitaker LC
    J Clin Psychol; 1984 May; 40(3):636-48. PubMed ID: 6746968
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functioning of acute and chronic schizophrenics on measures of abstract reasoning.
    Kingsley L
    J Clin Psychol; 1969 Apr; 25(2):144-7. PubMed ID: 5789199
    [No Abstract]   [Full Text] [Related]  

  • 76. Neuroleptic-like electroencephalographic changes in schizophrenics through biofeedback.
    Schneider SJ; Pope AT
    Biofeedback Self Regul; 1982 Dec; 7(4):479-90. PubMed ID: 6131700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of drugs on objective measures of thought disorder in schizophrenic patients.
    Payne RW
    Psychopharmacologia; 1972; 24(1):147-58. PubMed ID: 5018520
    [No Abstract]   [Full Text] [Related]  

  • 78. The psychopharmacology of violence with emphasis on schizophrenia, part 1: acute treatment.
    Citrome L
    J Clin Psychiatry; 2007 Jan; 68(1):163-4. PubMed ID: 17284144
    [No Abstract]   [Full Text] [Related]  

  • 79. [A further study of disturbance of the thinking process in schizophrenia (author's transl)].
    Chen CH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1979; 12(1):7-10. PubMed ID: 551875
    [No Abstract]   [Full Text] [Related]  

  • 80. Treating schizophrenia - Thinking beyond the choice of antipsychotic.
    Lugg W
    Aust N Z J Psychiatry; 2022 Mar; 56(3):214-215. PubMed ID: 34348478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.